Hematopoietic stem cells and hematopoiesis

Cancer Control

Volumn 10, Issue 1, 2003, Pages 9-16

  Smith, Clayton ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MCC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE PRODUCTION; CYTOPENIA; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOSTASIS; HUMAN; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0037283795     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480301000103     Document Type: Article

References (90)

1. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157-168.
2. Lemischka I. Stem cell dogmas in the genomics era. Rev Clin Exp Hematol. 2001;5:15-25.
3. Eaves C, Miller C, Cashman J, et al. Hematopoietic stem cells: inferences from in vivo assays. Stem Cells. 1997;15(suppl 1):1-5.
4. Jones RJ, Collector MI, Barber JP, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 1996;88:487-491.
5. Akashi K, Traver D, Kondo M, et al. Lymphoid development from hematopoietic stem cells. Int J Hematol. 1999;69:217-226.
6. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-245.
7. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999;27:1418-1427.
8. Sharkis SJ, Collector MI, Barber JP, et al. Phenotypic and functional characterization of the hematopoietic stem cell. Stem Cells. 1997;15(suppl 1):41-45.
9. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood. 1995;85:1006-1016.
10. Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
11. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
12. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990;4:220-232.
13. McCune JM. Development and applications of the SCID-hu mouse model. Semin Immunol. 1996;8:187-196.
14. Bhatia M, Bonnet D, Murdoch B, et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
15. Zanjani ED, Flake AW, Rice H, et al. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest. 1994;93:1051-1055.
16. Berenson RJ, Andrews RG, Bensinger WI, et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest. 1988;81:951-955.
17. Eaves C, Glimm H, Eisterer W, et al. Characterization of human hematopoietic cells with short-lived in vivo repopulating activity. Ann NY Acad Sci. 2001;938:63-71.
18. Manz MG, Miyamoto T, Akashi K, et al. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-11877.
19. Civin CI, Trischmann T, Kadan NS, et al. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol. 1996;14:2224-2233.
20. Terstappen LW, Huang S, Safford M, et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38-progenitor cells. Blood. 1991;77:1218-1227.
21. Lansdorp PM, Schmitt C, Sutherland HJ, et al. Hemopoietic stem cell characterization. Prog Clin Biol Res. 1992;377:475-486.
22. McNiece I. The CD34+Thyl+ cell population: are they all stem cells? Exp Hematol. 2000;28:1312-1314.
23. Miller JS, McCullar V, Punzel M, et al. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 1999;93:96-106.
24. Brugger W, Henschler R, Heimfeld S, et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood. 1994;84:1421-1426.
25. Stewart AK, Vescio R, Schiller G, et al. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. J Clin Oncol. 2001;19:3771-3779.
26. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337-1345.
27. Storms RW, Goodell MA, Fisher A, et al. Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood. 2000;96:2125-2133.
28. Ogawa M, Tajima F, Ito T, et al. CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations. Ann NY Acad Sci. 2001;938:139-145.
29. Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A. 1999;96:9118-9123.
30. Domen J, Weissman IL. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today. 1999;5:201-208.
31. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000;191:253-264.
32. Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol. 2002;3:323-328.
33. Hao QL, Thiemann FT, Petersen D, et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 1996;88:3306-3313.
34. Rogowski O, Sasson Y, Kassirer M, et al. Down-regulation of the CD62L antigen as a possible mechanism for neutrophilia during inflammation. Br J Haematol. 1998;101:666-669.
35. Koury MJ, Sawyer ST, Brandt SJ. New insights into erythropoiesis. Curr Opin Hematol. 2002;9:93-100.
36. Endo T, Odb A, Satoh I, et al. Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis. Exp Hematol. 2001;29:833-841.
37. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 2002;21:3295-3313.
38. Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene. 2002;21:3334-3358.
39. Crooks GM, Hao QL, Petersen D, et al. IL-3 increases production of B lymphoid progenitors from human CD34+CD38-cells. J Immunol. 2000;165:2382-2389.
40. Haylock DN, Horsfall MJ, Dowse TL, et al. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood. 1997;90:2260-2272.
41. Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134.
42. Kinashi T, Springer TA. Steel factor and c-kit regulate cellmatrix adhesion. Blood. 1994;83:1033-1038.
43. Mayani H, Little MT, Dragowska W, et al. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Exp Hematol. 1995;23:422-427.
44. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 1999;93:2431-2448.
45. Van Den Berg DJ, Sharma AK, Bruno E, et al. Role of members of the Wnt gene family in human hematopoiesis. Blood. 1998;92:3189-3202.
46. Gasparetto C, Laver J, Abboud M, et al. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. Blood. 1989;74:547-550.
47. Christopherson K 2nd, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells. 2001;19:388-396.
48. Broxmeyer HE. Regulation of hematopoiesis by chemokine family members. Int J Hematol. 2001;74:9-17.
49. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075-3085.
50. Wright DE, Bowman EP, Wagers AJ, et al. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med. 2002;195:1145-1154.
51. Scheele JS, Ripple D, Lubbert M. The role of ras and other low molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci. 2000;57:1950-1963.
52. Mahdi T, Alcalay D, Brizard A, et al. Role of p53 and RB on in vitro growth of normal umbilical cord blood cells. Exp Hematol. 1996;24:702-712.
53. Majka M, Ratajczak J, Gewirtz AM, et al. PI-3k-Akt axis inhibits apoptosis in normal human megakaryoblasts and is efficiently activated by thrombopoietin. Exp Hematol. 2000;28:1492.
54. Gimble JM, Robinson CE, Wu X, et al. The function of adipocytes in the bone marrow stroma: an update. Bone. 1996;19:421-428.
55. Taichman RS, Reilly MJ, Emerson SG. The hematopoietic microenvironment: osteoblasts and the hematopoietic microenvironment. Hematology. 2000;4:421-426.
56. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell. 2002;109:29-37.
57. Keller G, Wall C, Fong AZ, et al. Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. Blood. 1998;92:877-887.
58. Rempel RE, Saenz-Robles MT, Storms R, et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol Cell. 2000;6:293-306.
59. Elwood NJ, Zogos H, Pereira DS, et al. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL. Blood. 1998;91:3756-3765.
60. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol. 2002;2:162-174.
61. Liebermann DA, Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene. 2002;21:3391-3402.
62. Rolink AG, Schaniel C, Busslinger M, et al. Fidelity and infidelity in commitment to B-lymphocyte lineage development. Immunol Rev. 2000;175:104-111.
63. Ivanova NB, Dimos JT, Schaniel C, et al. A stem cell molecular signature. Science. 2002;298:601-604.
64. Park IK, He Y, Lin F, et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002;99:488-498.
65. Hackney JA, Charbord P, Brunk BP, et al. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci U S A. 2002;99:13061-13066.
66. Lemischka IR. The haematopoietic stem cell and its clonal progeny: mechanisms regulating the hierarchy of primitive haematopoietic cells. Cancer Surv. 1992;15:3-18.
67. King AG, Kondo M, Scherer DC, et al. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A. 2002;99:4508-4513.
68. Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000;407:383-386.
69. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-1234.
70. Goodell MA, Jackson KA, Majka SM, et al. Stem cell plasticity in muscle and bone marrow. Ann NY Acad Sci. 2001;938:208-220.
71. Hess DC, Hill WD, Martin-Studdard A, et al. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke. 2002;33:1362-1368.
72. Mezey E, Chandross KJ, Harta G, et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779-1782.
73. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
74. Howell J, Yoder M, Srour EF. Hematopoietic potential of murine skeletal muscle-derived CD45(-)Sca-1(+)c-kit(-) cells. Exp Hematol. 2002;30:915.
75. Bjornson CR, Rietze RL, Reynolds BA, et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science. 1999;283:534-537.
76. McKinney-Freeman SL, Jackson KA, Camargo FD, et al. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A. 2002;99:1341-1346.
77. Kawada H, Ogawa M. Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood. 2001;98:2008-2013.
78. Holden C, Vogel G. Stem cells. Plasticity: time for a reappraisal? Science. 2002;296:2126-2129.
79. Frisen J. Stem cell plasticity? Neuron. 2002;35:415-418.
80. Vogel G. Stem cell research. Studies cast doubt on plasticity of adult cells. Science. 2002;295:1989-1991.
81. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545.
82. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature. 2002;416:545-548.
83. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med. 2001;7:393-395.
84. Keller G, Snodgrass HR. Human embryonic stem cells: the future is now. Nat Med. 1999;5:151-152.
85. Thompson T. What is the promise of embryonic stem cell research? J Natl Cancer Inst. 2001;93:1445-1447.
86. Trounson AO. The derivation and potential use of human embryonic stem cells. Reprod Fertil Dev. 2001;13:523-532.
87. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 1995;92:7844-7848.
88. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 1995;7:862-869.
89. Sauvageau G, Thorsteinsdottir U, Eaves CJ, et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 1995;9:1753-1765.
90. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.